$1.410
+0.010 (+0.71%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
ENVB Prediction & Forecast by Similar Chart Analysis
Alphio's ENVB stock price prediction model matches the current Enveric Biosciences Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.43 (+1.17%). The 1-week path is $1.40 (-0.39%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Enveric Biosciences Inc Stock?
Enveric Biosciences Inc is currently not a strong buy due to its significant losses and low price performance. The current price is $1.41, down 61.58% year-to-date, which indicates a challenging financial environment. Additionally, the company's RSI is at 45.89, suggesting it is neither overbought nor oversold, but the forward P/E ratio is at 23.09, indicating potential overvaluation given the negative earnings. The main risk is its high operational losses, with a net income of -$4,040,207 expected in Q4 2025, which could further impact investor confidence.
ENVB stock price ended at $1.41 on Friday, after rising +0.71%
Enveric Biosciences Inc (ENVB) last closed at $1.41, gaining +0.71%. These facts feed the 1-day and 1-week ENVB price prediction above.
Forecast Drivers
Enveric Biosciences Inc (ENVB) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches ENVB, ranked by similarity.
Seasonality analysis for ENVB
Historically the probability of a positive November return for ENVB is 0.00%. January offers the highest probability of a positive month at 47.54%, while June is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for ENVB
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Nov 2026 | $1.51 | $1.59 | $1.68 | +13.04% |
| Dec 2026 | $1.05 | $1.18 | $1.41 | -16.45% |
In 2026, Enveric Biosciences Inc (ENVB) is projected to range from $1.05 to $1.68.
Enveric Biosciences Inc 2026 monthly forecast
In Nov 2026, Enveric Biosciences Inc is projected to average $1.59, with a low of $1.51 and high of $1.68.
In Dec 2026, Enveric Biosciences Inc is projected to average $1.18, with a low of $1.05 and high of $1.41.
Related articles
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.